Day 1 :
Keynote Forum
Jeevana Jyothi
Sri Padmavati Mahila Visvavidyalayam, India
Keynote: Clinical pharmacist’s involvement in hypertension management among women in tertiary care hospital
Time : 10:15-10:55
Biography:
Jeevana Jyothi has completed her BPharmacy and MPharmacy from Andhra University and PhD from Sri Padmavati Mahila Viswavidyalayam, India. She has teaching experience of 25 years and expertise in development of nanotechnology based drug delivery systems and novel formulations of anticancer drugs. Her contribution towards the development of formulation of targeted drug delivery systems of Curcumin and Tenoxicam helps the present miserable and prevalent problem of rheumatoid arthritis. She has published 19 research articles in Scopus indexed journals and one book entitled “Manual of Pharmaceutical Engineering”. She has also served as the Head of the Department of Pharmacy, Sri Padmavati Mahila Viswavidyalayam from 2009-2012 and as BOS Chairperson during 2010 and 2013.
Abstract:
Hypertension is an important risk factor for cardiovascular disease (CVD), affects 31% of adults (18 years and older) and contributes to coronary heart and cerebrovascular disease, the leading causes of death in women. The present study was to assess the effect of clinical pharmacist’s education and involvement in management of hypertension among women population in a tertiary care setting. A prospective interventional study was conducted for a period of six months in OBG department of a tertiary care hospital. Self-designed questionnaires were used to collect patient demographic and medical details from women of age group 18-60 years. Participants were allocated randomly into test and control group. Student paired t test was used to compare the groups before and after the intervention. p<0.05 was considered statistically significant. A total of 125 hypertensive women were enrolled in the study; 64 patients in test group and 61 in control group. On measuring the baseline blood pressure, the mean systolic blood pressure (SBP) was 13.4 mmHg in test group and 9.0 mmHg in control group. After intervention and education given through neatly prepared suggestions about exercise, diet management and life pattern. The mean SBP in test group was found to be 4.5 in test group and 7.5 in control group. The study was found to be significant with p value <0.05. The study highlights the pharmaceutical care provided by a clinical pharmacist achieved a significantly greater benefit in blood pressure reduction and control.
- Clinical Pharmacy and Its Key Role in Treatment | Pharma Research & Development | Clinical Pharmacy | Clinical Pharmacy and Drug Reactions
Location: Prague Room
Chair
Jeevana Jyothi B
Sri Padmavati Mahila Visvavidyalayam, India
Session Introduction
Norbert Nwankwo
University of Port Harcourt, Nigeria
Title: Digital signal processing-based techniques: Providing pharmacists with computerized procedures for investigations
Time : 11:15-11:45
Biography:
Norbert Nwankwo holds BPharm degree and has completed MPhil and PhD in Bioinformatics from De Montfort University, Leicester, United Kingdom. He is a Campaigner for the computerization of bioassessments teaches Pharmaco-informatics, research methods, etc. at the University of Port Harcourt, Nigeria. He has invented five computer-aided biomedical/bioengineering devices including Computer-Aided Drug Resistance Calculator using Digital Signal Processing technique called Informational Spectrum Method. He has also developed other devices which include Computer-Aided Druggability Detector, Computer-Aided Vaccine Potency Assessor, Computer-Aided Pharmaco-Investigator and Computer-Aided Drug Potency Decoder.
Abstract:
Background: Pharmaceutical dispensing practice has benefited from computerized, motorized (robotics) and Information Technology-based devices including Automated Dispensing Cabinets. Such devices are needed for pharmacological assessments. We had already developed one called Computer-Aided Pharmaco-Investigator.
Aim: The purpose of this presentation is to demonstrate to pharmacists how Pharmaco-Investigator works using potency assessments of two Anti-retroviral agents called Enfuvirfide and Sifuvirfide, and their protein target, N-terminal Heptad Repeat (NHR).
Method: The sequences of above-named agents are processed using a Digital Signal Processing (DSP) approach called Informational Spectrum Method (ISM) and nine pharmacological (physio-chemical and structural) parameters engaged.
Discussion: As shown in table 1, Sifuvirtide demonstrated greater potency than Enfuvirtide. This is in accord with the outcome of previous clinical investigation. This procedure is employable on all drugs as they are known to be either proteins, have protein targets or proteins encircling them.
Conclusion: This computerized (rational) and reliable device, which is employable on all drugs and is based on DSP technique that has served mankind for decades in areas such as radar technology has the tendency to revolutionalize pharmacological assessments.